It is required for the biosynthesis of proteins, co-enzymes, prosthetic groups, vitamins, amino acids like Cys and Met, GSH, and secondary metabolites such as GSL and sulfoflavonoids
PMC 7606590
In ob/ob mice, silencing ChREBP reduces hepatic triglyceride content specifically through inhibition of glucose-induced lipogenesis [49]
None of these routes has been characterized in published human pharmacokinetic studies
10.1038/s41598-017-10524-6 Summary Keywords valproic acid, acylcarnitines, fatty acid -oxidation, peroxisome proliferator-activated receptor , hepatotoxicity Citation Ma Y, Wang M, Guo S, Li T, Liu X and Zhao L (2022) The serum acylcarnitines profile in epileptic children treated with valproic acid and the protective roles of peroxisome proliferator-activated receptor a activation in valproic acid-induced liver injury
no dosing or administration guidance is provided